STAAR Surgical Global Vice President David Choromanski visits Shanghai Purui Eye Hospital
STAAR Surgical Global Vice President David Choromanski visited Shanghai Purui Eye Hospital for exchange on ICL implantation, clinical standards and quality assurance.
STAAR Surgical global executive visits for exchange
As one of the mainstream procedures for myopia correction, ICL implantation has attracted broad attention for its high-definition visual quality, reversibility and wide correction range. On May 19, STAAR Surgical Global Vice President David Choromanski visited Shanghai Purui Eye Hospital for observation and professional exchange, and met face to face with patients interested in myopia correction. Director Xiao Qirui attended the event.
Hospital representatives warmly welcomed Mr. Choromanski and thanked STAAR Surgical for its long-term support. The hospital noted that high-end equipment and technology are essential for better patient service. As an ophthalmic hospital providing ICL surgery, Shanghai Purui Eye Hospital has witnessed the development of high-definition, reversible myopia surgery in China and continues to refine its clinical practice.
Discussion on ICL surgical standards and international experience
Mr. Choromanski spoke highly of the hospital’s ICL program, including its surgical standardization and achievements in aligning with international practice.
He explained that ICL implantation has been used globally for nearly 30 years and is now available in more than 75 countries. ICL lenses are made from the proprietary collagen copolymer material Collamer, which has strong tissue compatibility and does not cause rejection. The surgery also preserves the integrity of the eye structure to the greatest extent possible, helping more patients enjoy the clear visual experience brought by ICL implantation.
Equipment and expert team support surgical quality
To ensure the safety and precision of ICL surgery, the hospital has introduced a series of professional ophthalmic examination systems, including UBM ultrasound biomicroscopy, IOLMaster 700, OCULUS Corvis ST corneal biomechanics analysis and Pentacam HR anterior-segment assessment. These platforms support a multi-layer safety system for myopia surgery.
The refractive surgery center expert team led by Xiao Qirui and Li Qing comprehensively evaluates each patient’s ocular condition based on preoperative examination results, performs precise calculations and customizes the lens for each eye, maximizing surgical safety, intraoperative precision and postoperative effectiveness.
Mr. Choromanski praised the hospital’s rigorous and standardized approach to preoperative examination and precise calculation for ICL implantation.
Continuing to improve ICL implantation quality
The hospital will continue improving the quality of ICL implantation, helping more patients with myopia experience the high-definition visual quality brought by ICL and move toward a clearer, brighter future.
